Dr. Richard Finn Describes the Phase III Trial of Palbociclib for Breast Cancer

onclivetv has 407 videos Subscribe Here

Description: Richard Finn, MD, Division of Hematology/Oncology at the Jonsson Comprehensive Cancer Center, University of California, Los Angeles, describes the design of a phase III trial looking at palbociclib (PD-0332991) for the treatment of patients with estrogen receptor-positive (ER+) metastatic breast cancer.

For more breast cancer resources, visit
Shared By : onclivetv
Posted on : 09/09/13
Added : 4 years ago
Category : Breast Cancer

More From onclivetv

Nothing found.